Pneumococcal Vaccine Syringes | Vaximune - G.C. Chemie

Advanced Pneumococcal Disease Immunization

When protecting vulnerable populations—ranging from pediatric patients to at-risk adults—against severe invasive pneumococcal diseases such as pneumonia, meningitis, and bacteremia, healthcare providers require reliable and targeted coverage. The Vaximune Pneumococcal Vaccine series provides specialized, active immunization designed strictly for intramuscular (IM) administration. Manufactured by Yuxi Walvax Biotechnology and imported by G.C. Chemie Pharmie Ltd., these ready-to-use pre-filled syringes ensure the steady clinical performance necessary for comprehensive clinical immunization protocols.

Why Choose Vaximune for Clinical Immunization?

Shielding patients from Streptococcus pneumoniae requires specific formulations based on patient age and health status. Clinical specialists benefit from having both advanced formulations available: the 13-Valent Conjugate vaccine induces robust, long-lasting T-cell dependent immune memory (crucial for infants and toddlers), while the 23-Valent Polysaccharide vaccine provides the broadest serotype coverage available for older adults and immunocompromised patients. These pre-filled syringes provide hospitals, clinics, and pediatricians with a trusted, ready-to-administer defense against pneumococcal infections.

Key Product Specifications & Clinical Benefits

Targeted Coverage Options: Available in two distinct clinical formulations—VAXIMUNE 13 (13-Valent Conjugate Vaccine, PCV13-TT) and VAXIMUNE 23 (23-Valent Polysaccharide Vaccine, PPSV23)—to meet diverse protocol requirements.

Precise Pre-filled Syringes: Each variant is supplied as a ready-to-use 0.5 mL single-dose pre-filled syringe, ensuring exact dosing, maximizing sterility, and minimizing preparation time.

Targeted Intramuscular Delivery: Formulated strictly for Intramuscular (IM) Injection, guaranteeing optimal absorption and systemic immune activation.

Comprehensive Protection: Designed to significantly reduce the incidence of pneumococcal pneumonia and invasive disease caused by the covered serotypes in susceptible populations.

Essential Storage & Usage Guidelines

Maintaining the delicate biological integrity of these vaccines is absolutely vital for their clinical efficacy.

Strict Cold Chain: Store the pre-filled syringes strictly in a refrigerator between 2°C to 8°C.

Do Not Freeze: Freezing will irrevocably destroy the active vaccine structure. Discard immediately if the vaccine has been frozen. Protect strictly from light during storage and transport. Refer to the enclosed prescribing information for exact age-based dosing schedules and sequential administration guidelines as directed by the physician.

Important Notice: Vaximune vaccines are Prescription Drugs. They must be prescribed, handled, and administered strictly by a Registered Medical Practitioner in a clinical or hospital setting. Keep all medicines safely out of the reach of children.